A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.
Clinical trial NCT06697184 · RECRUITING
Trial details
- NCT number
- NCT06697184
- Sponsor
- BeOne Medicines
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-23
- Primary completion
- 2029-11-30
- Enrollment
- 258
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.